Here, we represent a new strategy for combating oncogenic RAS-ERK signaling pathway by targeting the PHB-CRAF interaction in pancreatic ductal adenocarcinoma. The gene discussed is PHB1; the disease is pancreatic ductal adenocarcinoma.